(a) Schedule I shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. Each drug or substance has been assigned the DEA Controlled Substances Code Number set forth opposite it.
(b) Opiates. Unless specifically excepted or unless listed in another schedule, any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters and ethers, whenever the existence of such isomers, esters, ethers and salts is possible within the specific chemical designation (for purposes of 3-methylthiofentanyl only, the term isomer includes the optical and geometric isomers):
(1) Acetyl-alpha-methylfentanyl ( | 9815 |
(2) Acetylmethadol | 9601 |
(3) Acetyl fentanyl ( | 9821 |
(4) Acryl fentanyl ( | 9811 |
(5) AH-7921 (3,4-dichloro- | 9551 |
(6) Allylprodine | 9602 |
(7) Alphacetylmethadol (except levo-alphacetylmethadol also known as levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM) | 9603 |
(8) Alphameprodine | 9604 |
(9) Alphamethadol | 9605 |
(10) Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl] propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido) piperidine) | 9814 |
(11) Alpha-methylthiofentanyl ( | 9832 |
(12) Benzethidine | 9606 |
(13) Betacetylmethadol | 9607 |
(14) Beta-hydroxyfentanyl ( | 9830 |
(15) Beta-hydroxy-3-methylfentanyl (other name: N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide | 9831 |
(16) | 9836 |
(17) Betameprodine | 9608 |
(18) Betamethadol | 9609 |
(19) Betaprodine | 9611 |
(20) Butyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide) | 9822 |
(21) Clonitazene | 9612 |
(22) Cyclopropyl fentanyl ( | 9845 |
(23) Dextromoramide | 9613 |
(24) Diampromide | 9615 |
(25) Diethylthiambutene | 9616 |
(26) Difenoxin | 9168 |
(27) Dimenoxadol | 9617 |
(28) Dimepheptanol | 9618 |
(29) Dimethylthiambutene | 9619 |
(30) Dioxaphetyl butyrate | 9621 |
(31) Dipipanone | 9622 |
(32) Ethylmethylthiambutene | 9623 |
(33) Etonitazene | 9624 |
(34) Etoxeridine | 9625 |
(35) 4-Fluoroisobutyryl fentanyl ( | 9824 |
(36) Furanyl fentanyl ( | 9834 |
(37) Furethidine | 9626 |
(38) Hydroxypethidine | 9627 |
(39) Ketobemidone | 9628 |
(40) Levomoramide | 9629 |
(41) Levophenacylmorphan | 9631 |
(42) Methoxyacetyl fentanyl (2-methoxy- | 9825 |
(43) 3-Methylfentanyl ( | 9813 |
(44) 3-methylthiofentanyl ( | 9833 |
(45) Morpheridine | 9632 |
(46) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine) | 9661 |
(47) MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine) | (9560) |
(48) Noracymethadol | 9633 |
(49) Norlevorphanol | 9634 |
(50) Normethadone | 9635 |
(51) Norpipanone | 9636 |
(52) Ocfentanil ( | 9838 |
(53) | 9816 |
(54) | 9823 |
(55) Para-fluorofentanyl ( | 9812 |
(56) PEPAP (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine | 9663 |
(57) Phenadoxone | 9637 |
(58) Phenampromide | 9638 |
(59) Phenomorphan | 9647 |
(60) Phenoperidine | 9641 |
(61) Piritramide | 9642 |
(62) Proheptazine | 9643 |
(63) Properidine | 9644 |
(64) Propiram | 9649 |
(65) Racemoramide | 9645 |
(66) Tetrahydrofuranyl fentanyl ( | 9843 |
(67) Thiofentanyl ( | 9835 |
(68) Tilidine | 9750 |
(69) Trimeperidine | 9646 |
(70) U-47700 (3,4-Dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) | 9547 |
(c) Opium derivatives. Unless specifically excepted or unless listed in another schedule, any of the following opium derivatives, its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
(1) Acetorphine | 9319 |
(2) Acetyldihydrocodeine | 9051 |
(3) Benzylmorphine | 9052 |
(4) Codeine methylbromide | 9070 |
(5) Codeine-N-Oxide | 9053 |
(6) Cyprenorphine | 9054 |
(7) Desomorphine | 9055 |
(8) Dihydromorphine | 9145 |
(9) Drotebanol | 9335 |
(10) Etorphine (except hydrochloride salt) | 9056 |
(11) Heroin | 9200 |
(12) Hydromorphinol | 9301 |
(13) Methyldesorphine | 9302 |
(14) Methyldihydromorphine | 9304 |
(15) Morphine methylbromide | 9305 |
(16) Morphine methylsulfonate | 9306 |
(17) Morphine-N-Oxide | 9307 |
(18) Myrophine | 9308 |
(19) Nicocodeine | 9309 |
(20) Nicomorphine | 9312 |
(21) Normorphine | 9313 |
(22) Pholcodine | 9314 |
(23) Thebacon | 9315 |
(d) Hallucinogenic substances. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation, which contains any quantity of the following hallucinogenic substances, or which contains any of its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation (for purposes of this paragraph only, the term “isomer” includes the optical, position and geometric isomers):
(1) Alpha-ethyltryptamine | 7249 |
Some trade or other names: etryptamine; Monase; α-ethyl-1H-indole-3-ethanamine; 3-(2-aminobutyl) indole; α-ET; and AET. | |
(2) 4-bromo-2,5-dimethoxy-amphetamine | 7391 |
Some trade or other names: 4-bromo-2,5-dimethoxy-α-methylphenethylamine; 4-bromo-2,5-DMA | |
(3) 4-Bromo-2,5-dimethoxyphenethylamine | 7392 |
Some trade or other names: 2-(4-bromo-2,5-dimethoxyphenyl)-1-aminoethane; alpha-desmethyl DOB; 2C-B, Nexus. | |
(4) 2,5-dimethoxyamphetamine | 7396 |
Some trade or other names: 2,5-dimethoxy-α-methylphenethylamine; 2,5-DMA | |
(5) 2,5-dimethoxy-4-ethylamphet-amine | 7399 |
Some trade or other names: DOET | |
(6) 2,5-dimethoxy-4-(n)-propylthiophenethylamine (other name: 2C-T-7) | 7348 |
(7) 4-methoxyamphetamine | 7411 |
Some trade or other names: 4-methoxy-α-methylphenethylamine; paramethoxyamphetamine, PMA | |
(8) 5-methoxy-3,4-methylenedioxy-amphetamine | 7401 |
(9) 4-methyl-2,5-dimethoxy-amphetamine | 7395 |
Some trade and other names: 4-methyl-2,5-dimethoxy-α-methylphenethylamine; “DOM”; and “STP” | |
(10) 3,4-methylenedioxy amphetamine | 7400 |
(11) 3,4-methylenedioxymethamphetamine (MDMA) | 7405 |
(12) 3,4-methylenedioxy-N-ethylamphetamine (also known as N-ethyl-alpha-methyl-3,4(methylenedioxy)-phenethylamine, N-ethyl MDA, MDE, MDEA | 7404 |
(13) N-hydroxy-3,4-methylenedioxyamphetamine (also known as N-hydroxy-alpha-methyl-3,4(methylenedioxy)-phenethylamine, and N-hydroxy MDA | 7402 |
(14) 3,4,5-trimethoxy amphetamine | 7390 |
(15) 5-methoxy-N,N-dimethyltryptamine Some trade or other names: 5-methoxy-3-[2-(dimethylamino)ethyl]indole; 5-MeO-DMT | 7431 |
(16) Alpha-methyltryptamine (other name: AMT) | 7432 |
(17) Bufotenine | 7433 |
Some trade and other names: 3-(β-Dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)-5-indolol; N, N-dimethylserotonin; 5-hydroxy-N,N-dimethyltryptamine; mappine | |
(18) Diethyltryptamine | 7434 |
Some trade and other names: N,N-Diethyltryptamine; DET | |
(19) Dimethyltryptamine | 7435 |
Some trade or other names: DMT | |
(20) 5-methoxy-N,N-diisopropyltryptamine (other name: 5-MeO-DIPT) | 7439 |
(21) Ibogaine | 7260 |
Some trade and other names: 7-Ethyl-6,6β,7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano-5H-pyrido [1′, 2′:1,2] azepino [5,4-b] indole; Tabernanthe iboga | |
(22) Lysergic acid diethylamide | 7315 |
(23) Marihuana | 7360 |
(24) Mescaline | 7381 |
(25) Parahexyl - 7374; some trade or other names: 3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran; Synhexyl. | |
(26) Peyote | 7415 |
Meaning all parts of the plant presently classified botanically as | |
(Interprets 21 USC 812(c), Schedule I(c) (12)) | |
(27) N-ethyl-3-piperidyl benzilate | 7482 |
(28) N-methyl-3-piperidyl benzilate | 7484 |
(29) Psilocybin | 7437 |
(30) Psilocyn | 7438 |
(31) Tetrahydrocannabinols | 7370 |
Meaning tetrahydrocannabinols naturally contained in a plant of the genus Cannabis (cannabis plant), as well as synthetic equivalents of the substances contained in the cannabis plant, or in the resinous extractives of such plant, and/or synthetic substances, derivatives, and their isomers with similar chemical structure and pharmacological activity to those substances contained in the plant, such as the following: | |
1 cis or trans tetrahydrocannabinol, and their optical isomers | |
6 cis or trans tetrahydrocannabinol, and their optical isomers | |
3, 4 cis or trans tetrahydrocannabinol, and its optical isomers | |
(Since nomenclature of these substances is not internationally standardized, compounds of these structures, regardless of numerical designation of atomic positions covered.) | |
(32) Ethylamine analog of phencyclidine | 7455 |
Some trade or other names: N-ethyl-1-phenylcyclohexylamine, (1-phenylcyclohexyl)ethylamine, N-(1-phenylcyclohexyl)ethylamine, cyclohexamine, PCE | |
(33) Pyrrolidine analog of phencyclidine | 7458 |
Some trade or other names: 1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP | |
(34) Thiophene analog of phencyclidine | 7470 |
Some trade or other names: 1-[1-(2-thienyl)-cyclohexyl]-piperidine, 2-thienylanalog of phencyclidine, TPCP, TCP | |
(35) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine | 7473 |
Some other names: TCPy | |
(36) 4-methylmethcathinone (Mephedrone) | 1248 |
(37) 3,4-methylenedioxypyrovalerone (MDPV) | 7535 |
(38) 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E) | 7509 |
(39) 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D) | 7508 |
(40) 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C) | 7519 |
(41) 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I) | 7518 |
(42) 2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-2) | 7385 |
(43) 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-4) | 7532 |
(44) 2-(2,5-Dimethoxyphenyl)ethanamine (2C-H) | 7517 |
(45) 2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N) | 7521 |
(46) 2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P) | 7524 |
(47) 3,4-Methylenedioxy-N-methylcathinone (Methylone) | 7540 |
(48) (1-pentyl-1 | (7144) |
(49) [1-(5-fluoro-pentyl)-1 | (7011) |
(50) | (7048) |
(51) quinolin-8-yl 1-pentyl-1 | (7222) |
(52) quinolin-8-yl 1-(5-fluoropentyl)-1 | (7225) |
(53) | (7012) |
(54) | (7035) |
(55) 2-(4-iodo-2,5-dimethoxyphenyl)- | (7538) |
(56) 2-(4-chloro-2,5-dimethoxyphenyl)- | (7537) |
(57) 2-(4-bromo-2,5-dimethoxyphenyl)- | (7536) |
(58) Marihuana Extract - Meaning an extract containing one or more cannabinoids that has been derived from any plant of the genus Cannabis, other than the separated resin (whether crude or purified) obtained from the plant | (7350) |
(59) 4-methyl- | (1249) |
(60) 4-methyl- | (7498) |
(61) | (7545) |
(62) 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one (butylone, bk-MBDB) | (7541) |
(63) 2-(methylamino)-1-phenylpentan-1-one (pentedrone) | (1246) |
(64) 1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one (pentylone, bk-MBDP) | (7542) |
(65) 4-fluoro- | (1238) |
(66) 3-fluoro- | (1233) |
(67) 1-(naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one (naphyrone) | (1258) |
(68) | (7546) |
(69) | (7031) |
(70) | (7023) |
(71) [1-(5-fluoropentyl)-1 | (7024) |
(72) | (7032) |
(e) Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
(1) gamma-hydroxybutyric acid (some other names include GHB; gamma-hydroxybutyrate; 4-hydroxybutyrate; 4-hydroxybutanoic acid; sodium oxybate; sodium oxybutyrate) | 2010 |
(2) Mecloqualone | 2572 |
(3) Methaqualone | 2565 |
(f) Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers:
(1) Aminorex (Some other names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline; or 4,5-dihydro-5-phenly-2-oxazolamine) | 1585 |
(2) N-Benzylpiperazine (some other names: BZP, 1-benzylpiperazine) | 7493 |
(3) Cathinone | 1235 |
Some trade or other names: 2-amino-1-phenyl-1-propanone, alpha-aminopropiophenone, 2-aminopropiophenone, and norephedrone | |
(4) Fenethylline | 1503 |
(5) Methcathinone (Some other names: 2-(methylamino)-propiophenone; alpha-(methylamino)propiophenone; 2-(methylamino)-1-phenylpropan-1-one; alpha- | 1237 |
(6) (±) | 1590 |
(7) N-ethylamphetamine | 1475 |
(8) | 1480 |
(g) Cannabimimetic agents. Unless specifically exempted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances, or which contains their salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
(1) 5-(1,1-dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (CP-47,497) | 7297 |
(2) 5-(1,1-dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (cannabicyclohexanol or CP-47,497 C8-homolog) | 7298 |
(3) 1-pentyl-3-(1-naphthoyl)indole (JWH-018 and AM678) | 7118 |
(4) 1-butyl-3-(1-naphthoyl)indole (JWH-073) | 7173 |
(5) 1-hexyl-3-(1-naphthoyl)indole (JWH-019) | 7019 |
(6) 1-[2-(4-morpholinyl)ethyl]-3-(1-naphthoyl)indole (JWH-200) | 7200 |
(7) 1-pentyl-3-(2-methoxyphenylacetyl)indole (JWH-250) | 6250 |
(8) 1-pentyl-3-[1-(4-methoxynaphthoyl)]indole (JWH-081) | 7081 |
(9) 1-pentyl-3-(4-methyl-1-naphthoyl)indole (JWH-122) | 7122 |
(10) 1-pentyl-3-(4-chloro-1-naphthoyl)indole (JWH-398) | 7398 |
(11) 1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM2201) | 7201 |
(12) 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole (AM694) | 7694 |
(13) 1-pentyl-3-[(4-methoxy)-benzoyl]indole (SR-19 and RCS-4) | 7104 |
(14) 1-cyclohexylethyl-3-(2-methoxyphenylacetyl)indole 7008 (SR-18 and RCS-8) | 7008 |
(15) 1-pentyl-3-(2-chlorophenylacetyl)indole (JWH-203) | 7203 |
(h) Temporary listing of substances subject to emergency scheduling. Any material, compound, mixture or preparation which contains any quantity of the following substances:
(1) [Reserved] | |
(2) [Reserved] | |
(3) [Reserved] | |
(4) [Reserved] | |
(5) [Reserved] | |
(6) methyl 2-(1-(5-fluoropentyl)-1 | (7034) |
(7) methyl 2-(1-(5-fluoropentyl)-1 | (7033) |
(8) | (7049) |
(9) | (7010) |
(10) methyl 2-(1-(cyclohexylmethyl)-1 | (7042) |
(11) methyl 2-(1-(4-fluorobenzyl)-1 | (7020) |
(12) [Reserved] | |
(13) [Reserved] | |
(14) [Reserved] | |
(15) [Reserved] | |
(16) [Reserved] | |
(17) [Reserved] | |
(18) methyl 2-(1-(4-fluorobenzyl)-1 | (7021) |
(19) [Reserved] | |
(20) [Reserved] | |
(21) [Reserved] | |
(22) [Reserved] | |
(23) | (9840) |
(24) | (9823) |
(25) | (9837) |
(26) | (9826) |
(27) | (9827) |
(28) | (9847) |
(29) [Reserved] | |
(30) Fentanyl-related substances, their isomers, esters, ethers, salts and salts of isomers, esters and ethers | 9850 |
(i) Fentanyl-related substance means any substance not otherwise listed under another Administration Controlled Substance Code Number, and for which no exemption or approval is in effect under section 505 of the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 355], that is structurally related to fentanyl by one or more of the following modifications:
(A) Replacement of the phenyl portion of the phenethyl group by any monocycle, whether or not further substituted in or on the monocycle;
(B) Substitution in or on the phenethyl group with alkyl, alkenyl, alkoxyl, hydroxyl, halo, haloalkyl, amino or nitro groups;
(C) Substitution in or on the piperidine ring with alkyl, alkenyl, alkoxyl, ester, ether, hydroxyl, halo, haloalkyl, amino or nitro groups;
(D) Replacement of the aniline ring with any aromatic monocycle whether or not further substituted in or on the aromatic monocycle; and/or
(E) Replacement of the N-propionyl group by another acyl group.
(ii) This definition includes, but is not limited to, the following substances:
(A)-(B) [Reserved]
(31) Naphthalen-1-yl 1-(5-fluoropentyl)-1 | (7221) |
(32) | (7025) |
(33) 1-(4-cyanobutyl)- | (7089) |
(34) methyl 2-(1-(cyclohexylmethyl)-1 | (7044) |
(35) 1-(5-fluoropentyl)- | (7085) |
(36) | (7543) |
(37) ethyl 2-(1-(5-fluoropentyl)-1 | 7036 |
(38) methyl 2-(1-(5-fluoropentyl)-1 | 7041 |
(39) | 7047 |
(40) 1-(5-fluoropentyl)- | 7083 |
(41) (1-(4-fluorobenzyl)-1 | 7014 |
(42) | 7246 |
(43) | 7544 |
(44) 4-Methyl- | 7245 |
(45) 4′-Methyl- | 7446 |
(46) | 7548 |
(47) 4′-Chloro- | 7443 |
3. At 82 FR 32457, July 14, 2017, § 1308.11 was amended by adding (h)(17), effective July 14, 2017, until July 15, 2019. At 82 FR 47974, Oct. 16, 2017, § 1308.11 was amended by redesignating (h)(17) as paragraph (h)(14).
4. At 82 FR 49508, Oct. 26, 2017, § 1308.11 was amended by adding reserved paragraphs (h)(15) through (h)(18) and (h)(19), (20) and (21), effective Oct. 26, 2017,, through Oct. 28, 2019.
5. At 82 FR 51558, Nov. 3, 2017, § 1308.11 was amended by adding paragraph (h)(18), effective Nov. 3, 2017, through Nov. 4, 2019.
6. At 83 FR 472, Jan. 4, 2018, § 1308.11 was amended by adding paragraph (h)(22), effective Jan. 4, 2018, through Jan. 4, 2020.
7. At 83 FR 4584, Feb. 1, 2018, § 1308.11 was amended by adding paragraphs (h)(23) through (h)(29), effective Feb. 1, 2018, through Feb. 1, 2020.
8. At 83 FR 5191, Feb. 6, 2018, § 1308.11 was amended by adding paragraph (h)(30), effective Feb. 6, 2018, through Feb. 6, 2020.
9. At 83 FR 10368, Mar. 9, 2018, § 1308.11 was amended by revising paragraphs (h)(23) and (h)(29), effective Mar. 9, 2018, through Feb. 1, 2020.
10. At 83 FR 31882, July 10, 2018, § 1308.11 was amended by adding paragraphs (h)(31) through (h)(35) effective July 10, 2018 through July 10, 2020.
11. At 83 FR 44478, Aug. 31, 2018, § 1308.11 was amended by adding paragraph (h)(36) effective Aug. 31, 2018 through Aug. 31, 2020.
12. At 84 FR 15511, Apr. 16, 2019, § 1308.11 was amended by adding paragraphs (h)(37) through (h)(41) effective Apr. 16, 2019 through Apr. 16, 2021.
13. At 84 FR 34297, July 17, 2019, § 1308.11 was amended by adding paragraphs (h)(42) through (h)(47) effective July 18, 2019 through July 18, 2021.